These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

828 related items for PubMed ID: 21078681

  • 1. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL, Taylor FR, Friedman D, Newman L, Ge Y, Zhang Y, Hustad CM, Lasorda J, Fan X, Hewitt D, Ho T, Connor KM.
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [Abstract] [Full Text] [Related]

  • 2. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [Abstract] [Full Text] [Related]

  • 3. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 4. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC, Gendolla A, Gebert I, Beneke M.
    Headache; 2005 Jul; 45(7):874-82. PubMed ID: 15985104
    [Abstract] [Full Text] [Related]

  • 5. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
    Freitag F, Taylor FR, Hamid MA, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500
    [Abstract] [Full Text] [Related]

  • 6. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH, Winner P, Strohmaier K, Klipfel M, Peng Y, McCarroll K, Cady R, Lewis D, Nett R, Rizatriptan Protocol 059 and 061 Study Groups.
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [Abstract] [Full Text] [Related]

  • 7. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Nett R, Mannix LK, Mueller L, Rodgers A, Hustad CM, Skobieranda F, Ramsey KE.
    Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.
    Ho TW, Pearlman E, Lewis D, Hämäläinen M, Connor K, Michelson D, Zhang Y, Assaid C, Mozley LH, Strickler N, Bachman R, Mahoney E, Lines C, Hewitt DJ, Rizatriptan Protocol 082 Pediatric Migraine Study Group.
    Cephalalgia; 2012 Jul; 32(10):750-65. PubMed ID: 22711898
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC.
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [Abstract] [Full Text] [Related]

  • 10. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 11. Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets.
    Kolodny A, Polis A, Battisti WP, Johnson-Pratt L, Skobieranda F, Rizatriptan Protocol 052 Study Group.
    Cephalalgia; 2004 Jul; 24(7):540-6. PubMed ID: 15196296
    [Abstract] [Full Text] [Related]

  • 12. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    Cady R, Crawford G, Ahrens S, Hairwassers D, Getson A, Visser WH, Lines C, Rizatriptan-RPD Study Group.
    MedGenMed; 2001 Jun 01; 3(3):1. PubMed ID: 11549974
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
    Martin V, Cady R, Mauskop A, Seidman LS, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2008 Feb 01; 48(2):226-35. PubMed ID: 18005144
    [Abstract] [Full Text] [Related]

  • 14. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF, Foley KA, Barlas S, Solomon G, Hu XH.
    Clin Ther; 2006 Jun 01; 28(6):872-80. PubMed ID: 16860170
    [Abstract] [Full Text] [Related]

  • 15. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
    Loder E, Brandes JL, Silberstein S, Skobieranda F, Bohidar N, Wang L, Boyle D, Kolodny A, Guerra F, Santanello N, Johnson-Pratt L, Rizatriptan Protocol 060 Study Group.
    Headache; 2001 Sep 01; 41(8):745-53. PubMed ID: 11576197
    [Abstract] [Full Text] [Related]

  • 16. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan 01; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 17. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC, Gendolla A, Gebert I, Beneke M.
    Eur Neurol; 2005 Jan 01; 53 Suppl 1():41-8. PubMed ID: 15920337
    [Abstract] [Full Text] [Related]

  • 18. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.
    Headache; 2012 Apr 01; 52(4):530-43. PubMed ID: 22103635
    [Abstract] [Full Text] [Related]

  • 19. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ, Massiou H, Lainez JM, Cabarrocas X.
    Headache; 2004 Apr 01; 44(4):318-22. PubMed ID: 15109355
    [Abstract] [Full Text] [Related]

  • 20. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ.
    Headache; 2005 Sep 01; 45(8):983-91. PubMed ID: 16109111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.